Enliven Therapeutics, Inc. Board of Directors

Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. The company's lead product candidates comprise ELVN-001, which is being evaluated in a Phase 1 clinical trial in adults with chronic myeloid leukemia; and ELVN-002, a Phase 1 clinical trial in adults with solid tumors with HER2 alterations. The company is headquartered in Boulder, Colorado.

Mr. Samuel S. Kintz M.B.A.

Mr. Samuel S. Kintz M.B.A.

Co-Founder, CEO, Secretary & Director

Dr. Joseph P. Lyssikatos Ph.D.

Dr. Joseph P. Lyssikatos Ph.D.

Co-Founder & Chief Scientific Officer

Mr. Benjamin Hohl

Mr. Benjamin Hohl

CFO & Head of Corporate Development

Dr. Galya D. Blachman Esq., Ph.D.

Dr. Galya D. Blachman Esq., Ph.D.

Chief Legal Officer & Head of Business Development

Leaving Board of Directors Review Your about to visit the following url Invalid URL

Loading...
Comments


Comment created.